Michelle Fox Huffaker, MD

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

10 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huffaker’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

10 of 10 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$202,068

Medicare paid this office $202,068 for 90 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	35	$7,048	$119
New patient visit (45+ min)	26	$3,968	$153
Short return visit (20+ min)	26	$2,548	$80
Test for allergy using allergenic extract	16	$2,123	$4
Test to measure expiratory airflow and volume	32	$1,470	$27

See all 9 services

Sort by

Every Original Medicare service billed

Return visit (30+ min)	35	$7,048	$119
New patient visit (45+ min)	26	$3,968	$153
Short return visit (20+ min)	26	$2,548	$80
Test for allergy using allergenic extract	16	$2,123	$4
Test to measure expiratory airflow and volume	32	$1,470	$27
New patient visit (30+ min)	11	$1,165	$106
Test to measure the level of nitric oxide gas	34	$1,163	$20
Injection of drug or substance under skin or into muscle	11	$1,005	$14
Administration and interpretation of patient-focused health risk assessment	27	$143	$3

Who their Medicare patients are

90 Original Medicare patients in 2024. Average age 74 · Women 76% · Health risk score 0.90. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 1.

Conditions among them: High blood pressure 56% · Depression 18% · COPD 17% · Coronary heart disease 16% · Cancer 14%.

The office billed $527,411, Medicare allowed $256,413 and paid $202,068; for 11,622 services of 30 kinds; $174,119 of it was for drugs given in the office and $27,949 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	90	11,622	74	0.90	$527,411	$202,068
2023	99	10,665	73	0.91	$483,367	$189,850
2022	107	2,789	73	0.68	$185,582	$85,510
2021	95	2,260	71	0.72	$105,920	$41,037
2020	64	2,081	71	0.65	$121,633	$48,661
2019	103	2,594	73	0.80	$141,067	$52,163
2018	77	1,459	72	0.73	$69,980	$23,629
2015	40	41	69	3.42	$29,058	$6,368
2014	32	41	70	3.18	$19,209	$4,425

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Sort by

Original Medicare services billed in 2023

Return visit (30+ min)	30	$5,404	$110
New patient visit (45+ min)	36	$5,241	$146
Short return visit (20+ min)	28	$2,533	$82
Test for allergy using allergenic extract	21	$2,400	$4
New patient visit (30+ min)	12	$1,258	$105
Test to measure expiratory airflow and volume	26	$1,064	$27
Test to measure the level of nitric oxide gas	25	$743	$20
Administration and interpretation of patient-focused health risk assessment	22	$105	$3

2022: 5 services

Sort by

Original Medicare services billed in 2022

New patient visit (45+ min)	58	$8,307	$143
Return visit (30+ min)	42	$6,346	$102
Test for allergy using allergenic extract	23	$2,629	$4
Short return visit (20+ min)	27	$2,393	$83
Test to measure the level of nitric oxide gas	12	$244	$20

2021: 4 services

Sort by

Original Medicare services billed in 2021

New patient visit (45+ min)	51	$7,246	$142
Return visit (30+ min)	33	$5,057	$120
Test for allergy using allergenic extract	32	$4,527	$4
Short return visit (20+ min)	22	$1,804	$75

2020: 3 services

Sort by

Original Medicare services billed in 2020

New patient visit (45+ min)	26	$3,596	$138
Short return visit (20+ min)	29	$2,906	$71
Return visit (30+ min)	13	$1,355	$75

2019: 10 services

Sort by

Original Medicare services billed in 2019

New patient visit (45+ min)	54	$7,693	$142
Return visit (30+ min)	36	$4,850	$93
Test for allergy using allergenic extract	27	$3,348	$4
Short return visit (20+ min)	39	$3,132	$67
Test to measure expiratory airflow and volume	31	$1,501	$34
Professional service for multiple injections of allergen	11	$1,164	$9
Test to measure the level of nitric oxide gas	30	$877	$20
Test to measure expiratory airflow and volume changes before and after medication administration	11	$726	$60
Inhalation treatment for airway obstruction or sputum production	13	$264	$19
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	12	$1	None

2018: 7 services

Sort by

Original Medicare services billed in 2018

New patient visit (45+ min)	45	$6,542	$145
Return visit (30+ min)	33	$4,676	$94
Test for allergy using allergenic extract	25	$4,206	$5
Short return visit (20+ min)	22	$1,573	$66
Test to measure expiratory airflow and volume	28	$1,494	$36
Professional service for multiple injections of allergen	12	$1,021	$10
Test to measure the level of nitric oxide gas	21	$688	$21

2015: 1 service

Sort by

Original Medicare services billed in 2015

Initial hospital care with moderate level of medical decision making at least 75 minutes	37	$6,031	$159

Drugs they prescribed that Part D paid

$290,060

Pharmacies billed $290,060 in 2024. Most of that is one immune-globulin drugs at about $7,000 a fill for a small number of people.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 302) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.

151 generic and 151 brand-name prescriptions · $290,060 in drug cost · 15 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Gammagard Liquid	Immune globulin	12	$85,179	$7,098
Dupixent	None	12	$44,904	$3,742
Trelegy Ellipta	None	25	$15,059	$602
Breo Ellipta	None	14	$7,649	$546
Symbicort	None	16	$4,066	$254

See all 10 drugs

Sort by

Every Part D drug this clinician prescribed

Gammagard Liquid	Immune globulin	12	$85,179	$7,098
Dupixent	None	12	$44,904	$3,742
Trelegy Ellipta	None	25	$15,059	$602
Breo Ellipta	None	14	$7,649	$546
Symbicort	None	16	$4,066	$254
Epinephrine	None	17	$2,991	$176
Fluticasone-Salmeterol	None	19	$1,624	$85
Azelastine	None	25	$716	$29
Ipratropium	None	21	$515	$25
Montelukast	None	15	$80	$5

Year by year

Sort by

Part D prescribing by year

2024	302	84	0% (0)	50%	$290,060
2023	312	78	0% (0)	None	$241,156
2022	277	79	0% (0)	None	$62,351
2021	240	73	0% (0)	38%	$43,663
2020	287	75	0% (0)	48%	$52,155
2019	250	77	0% (0)	49%	$48,208
2018	161	49	0% (0)	47%	$19,490
2017	20	12	0% (0)	None	$1,200
2015	11	None	0% (0)	0%	$307
2014	181	23	0% (0)	None	$11,935
2013	237	40	5% (11)	22%	$14,467

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 11 drugs

Sort by

Part D drugs prescribed in 2023

Gammagard Liquid	Immune globulin	13	$87,889	$6,761
Trelegy Ellipta	None	23	$16,059	$698
Symbicort	None	32	$16,051	$502
Breo Ellipta	None	12	$7,163	$597
Advair Diskus	None	12	$6,578	$548
Epinephrine	None	18	$3,699	$205
Ipratropium	None	20	$1,128	$56
Azelastine	None	22	$571	$26
Albuterol Sulfate Hfa	None	14	$412	$29
Montelukast	None	26	$264	$10
Prednisone	None	12	$29	$2

2022: 9 drugs

Sort by

Part D drugs prescribed in 2022

Symbicort	17	$8,694	$511
Breo Ellipta	12	$7,341	$612
Odactra	12	$4,440	$370
Epinephrine	14	$3,653	$261
Ipratropium	40	$2,122	$53
Wixela Inhub	11	$2,084	$189
Azelastine	23	$1,550	$67
Albuterol Sulfate Hfa	11	$433	$39
Montelukast	27	$248	$9

2021: 9 drugs

Sort by

Part D drugs prescribed in 2021

Breo Ellipta	24	$11,816	$492
Spiriva Respimat	18	$8,778	$488
Symbicort	16	$5,676	$355
Epinephrine	16	$3,689	$231
Wixela Inhub	11	$2,328	$212
Azelastine	28	$1,223	$44
Ipratropium	12	$604	$50
Albuterol Sulfate Hfa	11	$453	$41
Montelukast	37	$410	$11

2020: 7 drugs

Sort by

Part D drugs prescribed in 2020

Breo Ellipta	37	$15,455	$418
Symbicort	22	$12,425	$565
Azelastine	39	$2,050	$53
Ipratropium	15	$1,215	$81
Albuterol Sulfate Hfa	22	$911	$41
Montelukast	33	$655	$20
Prednisone	13	$37	$3

2019: 5 drugs

Sort by

Part D drugs prescribed in 2019

Spiriva Respimat	23	$10,033	$436
Breo Ellipta	24	$9,423	$393
Azelastine	25	$1,532	$61
Ipratropium	13	$716	$55
Montelukast	39	$558	$14

2018: 5 drugs

Sort by

Part D drugs prescribed in 2018

Symbicort	16	$5,003	$313
Azelastine	15	$784	$52
Ventolin Hfa	12	$658	$55
Montelukast	24	$201	$8
Fluticasone Propionate	12	$68	$6

2014: 4 drugs

Sort by

Part D drugs prescribed in 2014

Metaxalone	11	$1,375	$125
Atorvastatin	21	$501	$24
Omeprazole	12	$267	$22
Amlodipine Besylate	14	$98	$7

2013: 5 drugs

Sort by

Part D drugs prescribed in 2013

Carbidopa-Levodopa	15	$2,627	$175
Atorvastatin	20	$745	$37
Omeprazole	14	$330	$24
Amlodipine Besylate	18	$148	$8
Hydrochlorothiazide	17	$70	$4

Money from drug and device companies

$2,048 in 2025

Sort by

Industry payments by year

2025	1	4	$1,966	$2,048
2023	1	1	None	$19
2022	1	1	None	$66
2021	2	2	$2,668	$2,680
2020	3	8	None	$132
2019	11	40	None	$844

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Takeda Pharmaceuticals U.S.A.	Takhzyro	$2,048	4 payments Consulting for Takhzyro · 2025-03-13 · $1,966 Meals for Takhzyro · 2025-02-13 · $18 Meals for Takhzyro · 2025-02-13 · $54 Meals for Eohilia · 2025-02-11 · $10

See all 4 published payments

Sort by

Every published payment

Takeda Pharmaceuticals U.S.A.	Consulting · 2025-03-13	Takhzyro	$1,966
Takeda Pharmaceuticals U.S.A.	Meals · 2025-02-13	Takhzyro	$18
Takeda Pharmaceuticals U.S.A.	Meals · 2025-02-13	Takhzyro	$54
Takeda Pharmaceuticals U.S.A.	Meals · 2025-02-11	Eohilia	$10

See earlier years (2023, 2022, 2021, 2020, 2019)

2023: $19

Sort by

Payments by company in 2023

GlaxoSmithKline	Nucala	$19	1 payment Meals for Nucala · 2023-11-30 · $19

2022: $66

Sort by

Payments by company in 2022

Genentech USA	None	$66	1 payment Meals · 2022-02-27 · $66

2021: $2,680

Sort by

Payments by company in 2021

Regeneron Pharmaceuticals	Dupixent	$2,668	1 payment Consulting for Dupixent · 2021-02-12 · $2,668
Horizon Therapeutics plc	Actimmune	$13	1 payment Education for Actimmune · 2021-03-26 · $13

2020: $132

Sort by

Payments by company in 2020

AstraZeneca Pharmaceuticals LP	Symbicort	$72	5 payments Meals for Fasenra · 2020-07-07 · $14 Meals for Symbicort · 2020-06-24 · $16 Meals · 2020-06-16 · $13 Meals · 2020-02-14 · $15 Meals · 2020-01-25 · $13
ALK-Abello	Odactra	$39	2 payments Meals for Odactra · 2020-05-27 · $18 Meals for Odactra · 2020-02-28 · $20
GlaxoSmithKline	Nucala	$21	1 payment Meals for Nucala · 2020-06-02 · $21

2019: $844

Sort by

Payments by company in 2019

Teva Pharmaceuticals USA	Cinqair	$246	8 payments Meals for Cinqair · 2019-08-19 · $83 Meals for Cinqair · 2019-07-22 · $25 Meals for Cinqair · 2019-05-24 · $14 Meals for Cinqair · 2019-05-23 · $1 Meals for Cinqair · 2019-04-05 · $17 Meals for Cinqair · 2019-04-02 · $1 Meals for Cinqair · 2019-02-22 · $68 Meals for Cinqair · 2019-02-21 · $38
ALK-Abello	Odactra	$119	6 payments Meals for Odactra · 2019-12-16 · $13 Meals for Odactra · 2019-10-04 · $25 Meals for Odactra · 2019-08-15 · $25 Meals for Odactra · 2019-04-30 · $21 Meals for Odactra · 2019-03-25 · $16 Meals for Odactra · 2019-01-28 · $18
AstraZeneca Pharmaceuticals LP	Symbicort	$94	5 payments Meals for Symbicort · 2019-09-13 · $23 Meals for Symbicort · 2019-05-31 · $11 Meals for Fasenra · 2019-05-17 · $19 Meals for Symbicort · 2019-04-12 · $21 Meals for Symbicort · 2019-01-18 · $20
GlaxoSmithKline	Nucala	$89	5 payments Meals for Nucala · 2019-12-14 · $20 Meals for Nucala · 2019-07-01 · $20 Meals for Nucala · 2019-05-13 · $21 Meals for Nucala · 2019-02-05 · $13 Meals for Nucala · 2019-01-14 · $15
Novartis Pharmaceuticals	Xolair	$88	4 payments Meals for Xolair · 2019-06-10 · $23 Meals for Xolair · 2019-04-22 · $21 Meals for Xolair · 2019-03-15 · $21 Meals for Xolair · 2019-02-15 · $23
Covis Pharma B.V.	Alvesco	$42	3 payments Meals for Alvesco · 2019-06-17 · $13 Meals for Alvesco · 2019-04-15 · $14 Meals for Alvesco · 2019-01-07 · $15
Shire North American Group	Cuvitru	$41	2 payments Meals for Cuvitru · 2019-06-28 · $23 Meals for Cuvitru · 2019-02-08 · $17
OptiNose US	Xhance	$39	2 payments Meals for Xhance · 2019-08-29 · $22 Meals for Xhance · 2019-07-08 · $17
Boehringer Ingelheim Pharmaceuticals	Spiriva Respimat	$36	2 payments Meals for Stiolto Respimat · 2019-07-29 · $17 Meals for Spiriva Respimat · 2019-05-20 · $18
Kaleo	Auvi-Q	$32	2 payments Meals for Auvi-Q · 2019-11-22 · $16 Meals for Auvi-Q · 2019-01-11 · $17
Regeneron Healthcare Solutions	Dupixent	$18	1 payment Meals for Dupixent · 2019-07-15 · $18

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 69.9 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1407141641
Licence: MA 247618
Trained: Harvard Medical School, 2011
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207K00000X (207K00000X); Internal medicine (207R00000X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2011-06-16
NPI last updated: 2025-09-04
NPI record certified: 2025-09-04

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 725 Welch Rd, Palo Alto, CA, 94304